Mitomycin-C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: Cumulative toxicity of an old drug in a new era

Clinical Colorectal Cancer

Volumn 10, Issue 2, 2011, Pages 142-145

  El Ghazal, Roland ^a   Podoltsev, Nikolai ^b   Marks, Peter ^b   Chu, Edward ^b   Wasif Saif, Muhammad ^c  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b YALE CANCER CENTER   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Anal squamous cell carcinoma; Anemia; Drug toxicity; Prednisone; Thrombocytopenia

Indexed keywords

CAPECITABINE; CETUXIMAB; CISPLATIN; CREATININE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRINOGEN; FLUOROURACIL; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MITOMYCIN C; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE;

AGED; ANAL SQUAMOUS CELL CARCINOMA; ANEMIA; ANUS CARCINOMA; ANUS FISTULA; ARTICLE; BLOOD CELL COUNT; BLOOD SMEAR; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CAUCASIAN; CELL; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); COOMBS TEST; CYTOGENETICS; DISEASE DURATION; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; INGUINAL LYMPH NODE; LYMPHADENOPATHY; MULTIMODALITY CANCER THERAPY; PARTIAL THROMBOPLASTIN TIME; PROTEIN EXPRESSION; RADIATION DOSE; RETICULOCYTE COUNT; SCHISTOCYTE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT WITHDRAWAL;

EID: 79959340173     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.03.012     Document Type: Article

References (22)

1. Evan Sadler J. TTP: A moving target, hematology. ASH Education Program Book 2006:415-20.
2. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005; 31:681-90. (Pubitemid 43063086)
3. Wu DC, Liu JM, Chen YM, et al. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. Jpn J Clin Oncol 1997; 27:115-8. (Pubitemid 127518581)
4. Nigro ND, Seydel HG, Considine B, et al. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983; 51: 1826-9. (Pubitemid 13093950)
5. Valavaara R, Slaughter D. Renal complications of mitomycin-C therapy with special reference to the total dose. Cancer 1985; 55:47-50. (Pubitemid 15198197)
6. Proia AD, Harden EA, Silberman HR. Mitomycin-induced hemolytic-uremic syndrome. Arch Pathol Lab Med 1984; 108:959-62. (Pubitemid 15189163)
7. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989; 7:781-9. (Pubitemid 19145601)
8. Hanna WT, Krauss S, Regester RF, et al. Renal disease after mitomycin-C therapy. Cancer 1981; 48:2583-8.
9. Perry MC. Vascular toxicity of antineoplastic agents. In:The Chemotherapy Source Book , 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2007:249.
10. Hofheinz R-D, Hartmann JT, Willer A, et al. Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial. Br J Cancer 2004; 91:834-8. (Pubitemid 39273771)
11. Lê LH, Chetty R, Moore MJ. Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol 2005; 124:20-3. (Pubitemid 40944369)
12. Francis KK, Kalyanam N, Terrell DR, et al. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 2007; 12:11-9. (Pubitemid 46143499)
13. Ruggenenti P, Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 1990; 4:219-41. (Pubitemid 20095147)
14. Cattell V. Mitomycin induced hemolytic uremic kidney: an experimental model in the rat. Am J Pathol 1985; 121:88-95. (Pubitemid 16232393)
15. Korec S, Schein PS, Smith FP, et al. Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986; 4:210-5. (Pubitemid 16161037)
16. Snyder HW Jr., Mittelman A, Oral A, et al. Treatment of cancer chemotherapy associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993; 71:1882-92. (Pubitemid 23067409)
17. Watson PR, Guthrie TH, Jr, Caruana RJ. Cisplatin associated hemolytic uremic syndrome by protein A immunoadsorption of plasma. Successful treatment with a staphyloccocal protein A column. Cancer 1989; 64:1400-3.
18. Cantrell JE Jr, Philips TM, Schein PS. Carcinoma associated hemolytic uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985; 3:723-34. (Pubitemid 15119245)
19. Khansur T, Kennedy A. Case report: cisplatin induced hemolytic uremic syndrome. Am J Med Sci 1991; 301:390-2.
20. Doll DC, Weiss RB. Hemolytic anemia associated with antineoplastic agents. Cancer Treat Rep 1985; 69:777-82. (Pubitemid 15229413)
21. Garibotto G, Acquarone N, Saffioti S, et al. Successful treatment of mitomycin C associated hemolytic uremic syndrome by plasmapheresis. Nephron 1989; 51:409-12. (Pubitemid 19056737)
22. Poch E, Almirall J, Nicolas JM, et al. Treatment of mitomycin C associated hemolytic uremic syndrome with plasmapheresis. Nephron 1990; 55:89-90. (Pubitemid 20135113)